These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 24624806)

  • 1. [Results of antioxidant therapy for non-proliferative diabetic retinopathy in patients with type 2 diabetes mellitus].
    Alekseev IB; Vorob'eva IV; Mikhaleva LG; Gigineishvili DN; Merkushenkova DA
    Vestn Oftalmol; 2013; 129(6):66-71. PubMed ID: 24624806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of the use of antioxidant and angioprotective agents in type 2 diabetes patients with diabetic retinopathy and age-related macular degeneration].
    Moshetova LK; Vorob'eva IV; Alekseev IB; Mikhaleva LG
    Vestn Oftalmol; 2015; 131(3):34-44. PubMed ID: 26310005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Results of laser photocoagulation in patients with diabetic retinopathy developed as a complication of diabetes type 2].
    Wilczyński M; Dzivgielewski K
    Klin Oczna; 2006; 108(1-3):66-9. PubMed ID: 16883944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [On some pathogenic features of diabetic retinopathy in type II diabetes mellitus and the role of antioxidants and ginkgo biloba].
    Alekseev IB; Kochergin SA; Vorob'eva IV; Mikhaleva LG
    Vestn Oftalmol; 2013; 129(3):89-93. PubMed ID: 23879031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optical coherence tomography.
    Kumar A; Sinha S
    Ophthalmology; 2008 Feb; 115(2):417-8; author reply 418. PubMed ID: 18243920
    [No Abstract]   [Full Text] [Related]  

  • 6. Enhanced depth imaging optical coherence tomography in type 2 diabetes.
    Querques G; Lattanzio R; Querques L; Del Turco C; Forte R; Pierro L; Souied EH; Bandello F
    Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6017-24. PubMed ID: 22879414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of complex therapy with emoxipin on the course of diabetic retinopathy].
    Kozlov SA; Khyshiktuev BS; Logunov NA
    Vestn Oftalmol; 2003; 119(2):28-30. PubMed ID: 13678005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema.
    Mirshahi A; Shenazandi H; Lashay A; Faghihi H; Alimahmoudi A; Dianat S
    Retina; 2010 Feb; 30(2):254-9. PubMed ID: 20057344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of retinal neovascularization in the second eye in patients with proliferative diabetic retinopathy.
    Vésteinsdóttir E; Björnsdóttir S; Hreidarsson AB; Stefánsson E
    Acta Ophthalmol; 2010 Jun; 88(4):449-52. PubMed ID: 19604165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optical coherence tomographic pattern may predict visual outcome after intravitreal triamcinolone for diabetic macular edema.
    Gibran SK; Khan K; Jungkim S; Cleary PE
    Ophthalmology; 2007 May; 114(5):890-4. PubMed ID: 17467527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visual dysfunction after panretinal photocoagulation in patients with severe diabetic retinopathy and good vision.
    Shimura M; Yasuda K; Nakazawa T; Tamai M
    Am J Ophthalmol; 2005 Jul; 140(1):8-15. PubMed ID: 15939392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OCT and cataract.
    Falavarjani KG; Modarres M; Nikeghbali A
    Ophthalmology; 2010 Apr; 117(4):849; author reply 849-50. PubMed ID: 20346827
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of argon laser photocoagulation on diabetic retinopathy].
    Wei ZY; Hu SX; Tang N; Wu J; Wang J
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Nov; 24(11):1313-5. PubMed ID: 15567792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.
    Haritoglou C; Kook D; Neubauer A; Wolf A; Priglinger S; Strauss R; Gandorfer A; Ulbig M; Kampik A
    Retina; 2006; 26(9):999-1005. PubMed ID: 17151486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of glycaemic control and the introduction of insulin therapy on retinopathy in non-insulin-dependent diabetes mellitus.
    Henricsson M; Nilsson A; Janzon L; Groop L
    Diabet Med; 1997 Feb; 14(2):123-31. PubMed ID: 9047089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The status of diabetic retinopathy and diabetic macular edema in patients with type 2 diabetes: a survey from Beixinjing District of Shanghai city in China.
    Wang N; Xu X; Zou H; Zhu J; Wang W; Ho PC
    Ophthalmologica; 2008; 222(1):32-6. PubMed ID: 18097178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of manganese superoxide dismutase gene polymorphism (V16A) with diabetic macular edema in Korean type 2 diabetic patients.
    Lee SJ; Choi MG
    Metabolism; 2006 Dec; 55(12):1681-8. PubMed ID: 17142144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinal layer thickness changes in eyes with preserved visual acuity and diffuse diabetic macular edema on optical coherence tomography.
    Somfai GM; Tátrai E; Ferencz M; Puliafito CA; Debuc DC
    Ophthalmic Surg Lasers Imaging; 2010; 41(6):593-7. PubMed ID: 20839667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of macular edema after cataract surgery in patients with diabetes using optical coherence tomography.
    Kim SJ; Equi R; Bressler NM
    Ophthalmology; 2007 May; 114(5):881-9. PubMed ID: 17275910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetic macular edema: correlation between microperimetry and optical coherence tomography findings.
    Vujosevic S; Midena E; Pilotto E; Radin PP; Chiesa L; Cavarzeran F
    Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):3044-51. PubMed ID: 16799051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.